Pfizer Chief Executive Ian Read told WSJ the company was "moving on" after dropping its pursuit of British rival AstraZeneca, leaving both drug makers to overcome aging pipelines and market pressures alone.
from WSJ.com: US Business http://ift.tt/1msxMZy
via IFTTT
from WSJ.com: US Business http://ift.tt/1msxMZy
via IFTTT
No comments:
Post a Comment